Castellaneta A - Search Results

1

Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence.

Castellaneta A, Massaro A, Rendina M, D'Errico F, Carparelli S, Rizzi SF, Thomson AW, Di Leo A. Castellaneta A, et al. Transplant Res. 2016 Jan 20;5:1. doi: 10.1186/s13737-016-0030-7. eCollection 2016. Transplant Res. 2016. PMID: 26798454 Free PMC article.

2

HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance.

Castellaneta A, Mazariegos GV, Nayyar N, Zeevi A, Thomson AW. Castellaneta A, et al. Transplantation. 2011 May 27;91(10):1132-40. doi: 10.1097/TP.0b013e31821414c9. Transplantation. 2011. PMID: 21423069 Free PMC article.

3

Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial.

Rendina M, D'Amato M, Castellaneta A, Castellaneta NM, Brambilla N, Giacovelli G, Rovati L, Rizzi SF, Zappimbulso M, Bringiotti RS, Di Leo A. Rendina M, et al. Among authors: castellaneta a, castellaneta nm. Transpl Int. 2014 Jul;27(7):696-704. doi: 10.1111/tri.12324. Epub 2014 May 10. Transpl Int. 2014. PMID: 24673819 Free article. Clinical Trial.

4

Tolerogenic plasmacytoid DC.

Matta BM, Castellaneta A, Thomson AW. Matta BM, et al. Among authors: castellaneta a. Eur J Immunol. 2010 Oct;40(10):2667-76. doi: 10.1002/eji.201040839. Eur J Immunol. 2010. PMID: 20821731 Free PMC article. Review.

5

Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.

Losurdo G, Castellaneta A, Rendina M, Carparelli S, Leandro G, Di Leo A. Losurdo G, et al. Among authors: castellaneta a. Aliment Pharmacol Ther. 2018 Mar;47(6):704-714. doi: 10.1111/apt.14521. Epub 2018 Jan 22. Aliment Pharmacol Ther. 2018. PMID: 29359341

6

Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.

Castellaneta A, Abe M, Morelli AE, Thomson AW. Castellaneta A, et al. Hum Immunol. 2004 Feb;65(2):104-13. doi: 10.1016/j.humimm.2003.10.006. Hum Immunol. 2004. PMID: 14969765

7

Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice.

Castellaneta A, Di Leo A, Francavilla R, Margiotta M, Barone M, Amoruso A, Troiani L, Thomson AW, Francavilla A. Castellaneta A, et al. Hepatology. 2006 Apr;43(4):807-16. doi: 10.1002/hep.21098. Hepatology. 2006. PMID: 16557552

8

Dendritic cell immunobiology in relation to liver transplant outcome.

Sumpter TL, Lunz JG 3rd, Castellaneta A, Matta B, Tokita D, Turnquist HR, Mazariegos GV, Demetris AJ, Thomson AW. Sumpter TL, et al. Among authors: castellaneta a. Front Biosci (Elite Ed). 2009 Jun 1;1(1):99-114. doi: 10.2741/E11. Front Biosci (Elite Ed). 2009. PMID: 19482629 Free article. Review.

9

NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.

Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. Castellaneta A, et al. J Immunol. 2009 Dec 1;183(11):6922-32. doi: 10.4049/jimmunol.0900582. Epub 2009 Nov 4. J Immunol. 2009. PMID: 19890047 Free PMC article.

10

Monitoring the operationally tolerant liver allograft recipient.

Castellaneta A, Thomson AW, Nayyar N, de Vera M, Mazariegos GV. Castellaneta A, et al. Curr Opin Organ Transplant. 2010 Feb;15(1):28-34. doi: 10.1097/MOT.0b013e328334269a. Curr Opin Organ Transplant. 2010. PMID: 19890211 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page